Related references
Note: Only part of the references are listed.Periosteal PTHrP Regulates Cortical Bone Remodeling During Fracture Healing
Meina Wang et al.
BONE (2015)
Diabetes mellitus and its association with central obesity and disability among older adults: A global perspective
Stefanos Tyrovolas et al.
EXPERIMENTAL GERONTOLOGY (2015)
Parathyroid hormone-related protein (107-111) improves the bone regeneration potential of gelatin-glutaraldehyde biopolymer-coated hydroxyapatite
Daniel Lozano et al.
ACTA BIOMATERIALIA (2014)
Effects of Parathyroid Hormone on Bone Mass, Bone Strength, and Bone Regeneration in Male Rats With Type 2 Diabetes Mellitus
Christine Hamann et al.
ENDOCRINOLOGY (2014)
Tissue-Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody
Michael S. Ominsky et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Functional Roles of the Nuclear Localization Signal of Parathyroid Hormone-Related Protein (PTHrP) in Osteoblastic Cells
A. Garcia-Martin et al.
MOLECULAR ENDOCRINOLOGY (2014)
Treatment with N- and C-Terminal Peptides of Parathyroid Hormone-Related Protein Partly Compensate the Skeletal Abnormalities in IGF-I Deficient Mice
Lourdes Rodriguez-de la Rosa et al.
PLOS ONE (2014)
TISSUE ENGINEERED BONE USING SELECT GROWTH FACTORS: A COMPREHENSIVE REVIEW OF ANIMAL STUDIES AND CLINICAL TRANSLATION STUDIES IN MAN
D. Gothard et al.
EUROPEAN CELLS & MATERIALS (2014)
Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies
Pedro Esbrit et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Haploinsufficiency of endogenous parathyroid hormone-related peptide impairs bone fracture healing
Yin-He Wang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2013)
Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus
Christine Hamann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
A tissue engineering approach based on the use of bioceramics for bone repair
Antonio J. Salinas et al.
BIOMATERIALS SCIENCE (2013)
Diabetes and bone fragility: a dangerous liaison
F. Conti et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2013)
In vivo osteointegration of three-dimensional crosslinked gelatin-coated hydroxyapatite foams
J. Gil-Albarova et al.
ACTA BIOMATERIALIA (2012)
Biological performance of hydroxyapatite-biopolymer foams: In vitro cell response
Monica Cicuendez et al.
ACTA BIOMATERIALIA (2012)
Endogenous tissue engineering: PTH therapy for skeletal repair
Masahiko Takahata et al.
CELL AND TISSUE RESEARCH (2012)
Bone, sweet bone-osteoporotic fractures in diabetes mellitus
Christine Hamann et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Osteoporosis, frailty and fracture: implications for case finding and therapy
Joop P. van den Bergh et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low-turnover osteopaenia
D. Lozano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
Ann V. Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The Diabetic Bone: A Cellular and Molecular Perspective
Robert Blakytny et al.
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS (2011)
The osteoinductive properties of mesoporous silicate coated with osteostatin in a rabbit femur cavity defect model
Cynthia G. Trejo et al.
BIOMATERIALS (2010)
Hip and calcaneal bone loss increase with advancing age: Longitudinal results from the study of osteoporotic fractures
Kristine E. Ensrud et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Aging and Bone
A. L. Boskey et al.
JOURNAL OF DENTAL RESEARCH (2010)
Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States
Bernardo Nuche-Berenguer et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
Role of Parathyroid Hormone-Related Protein in the Decreased Osteoblast Function in Diabetes-Related Osteopenia
Daniel Lozano et al.
ENDOCRINOLOGY (2009)
Bone regeneration is regulated by Wnt signaling
Jae-Beorn Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis - A randomized trial
Susan L. Greenspan et al.
ANNALS OF INTERNAL MEDICINE (2007)
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture
Mohsen Janghorbani et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Osteoporosis in patients with diabetes mellitus
Lorenz C. Hofbauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture
M. Saito et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34
DS Miao et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone
TT Andreassen et al.
ACTA ORTHOPAEDICA SCANDINAVICA (2001)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Parathyroid hormone-related protein analog R8-66271 is an effective therapy for impaired bone healing in rabbits on corticosteroid therapy
MPG Bostrom et al.
BONE (2000)
Share Paper
